Salit, Rachel B. https://orcid.org/0000-0002-4060-9393
Article History
Received: 5 August 2021
Revised: 7 February 2022
Accepted: 16 March 2022
First Online: 6 April 2022
Competing interests
: The author has received research funding from the Incyte Corporation and participated on an advisory board for CTI Biopharma.